Repligen (RGEN) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.22% |
| Dec 31, 2025 | 0.51% |
| Sep 30, 2025 | -4.30% |
| Jun 30, 2025 | -6.59% |
| Mar 31, 2025 | -11.19% |
| Dec 31, 2024 | 22.15% |
| Sep 30, 2024 | -24.44% |
| Jun 30, 2024 | -13.13% |
| Mar 31, 2024 | -19.61% |
| Dec 31, 2023 | -39.59% |
| Sep 30, 2023 | -9.87% |
| Jun 30, 2023 | 35.17% |
| Mar 31, 2023 | 18.32% |
| Dec 31, 2022 | 71.81% |
| Sep 30, 2022 | 165.42% |
| Jun 30, 2022 | 63.10% |
| Mar 31, 2022 | 60.26% |
| Dec 31, 2021 | 66.73% |
| Sep 30, 2021 | 64.54% |
| Jun 30, 2021 | 52.45% |
| Mar 31, 2021 | 60.06% |
| Dec 31, 2020 | 64.91% |
| Sep 30, 2020 | 41.55% |
| Jun 30, 2020 | 33.49% |
| Mar 31, 2020 | 24.14% |
| Dec 31, 2019 | -232.58% |
| Sep 30, 2019 | 29.16% |
| Jun 30, 2019 | 28.90% |
| Mar 31, 2019 | 16.05% |
| Dec 31, 2018 | 8.67% |
| Sep 30, 2018 | -0.39% |
| Jun 30, 2018 | -6.88% |
| Mar 31, 2018 | 11.01% |
| Dec 31, 2017 | -12.64% |
| Sep 30, 2017 | -16.93% |
| Jun 30, 2017 | 32.94% |
| Sep 30, 2016 | 46.67% |
| Jun 30, 2016 | 119.04% |
| Mar 31, 2016 | 29.63% |
| Dec 31, 2015 | 36.92% |
| Sep 30, 2015 | 47.60% |
| Jun 30, 2015 | 38.97% |